Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer. - Wikidata - awgldk - TriplyDB

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

http://www.wikidata.org/entity/Q34528276

about

Treatment Patterns and Outcomes in Patients with KRAS Wild-Type Metastatic Colorectal Cancer Treated in First Line with Bevacizumab- or Cetuximab-Containing Regimens.Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer.

P2860

Q47425132-891681EE-434A-455B-9EA8-1E02563AAD51 Q55342871-D3AEB8B8-5AC1-44AC-8075-97798194EEA6

P2860

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

http://www.wikidata.org/entity/Q34528276

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

@ast

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

@en

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

@nl

type

label

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

@ast

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

@en

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

@nl

prefLabel

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

@ast

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

@en

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

@nl

P1433

Q34528276-E68F0DB3-8E3C-46F2-A5AD-9EBA143B9999

P1476

Q34528276-89C859B6-27A1-4D44-888A-C82B650E1956

P2093

Q34528276-06460587-FAF5-485D-8237-E32ED2C38964

Q34528276-4E877CDB-174E-4608-AE1F-E9D650080C19

Q34528276-6B8FF9EB-9669-4D66-9668-F7CF758EC337

Q34528276-83F61467-45B9-4F8A-BC28-C1977732D4D9

Q34528276-A6F934FD-58A3-4064-B2CC-0B42472C38B5

Q34528276-AC41D183-C215-46C1-A39E-FC11DCD55A2E

Q34528276-B383FDF3-DB09-48C9-A3F8-B9945EB9C223

Q34528276-B3D5FB53-1EE4-4224-BC65-293617525F33

Q34528276-EF23A9EB-F9FB-4C1F-9222-69F142AEA2BF

P2860

Q34528276-0038EC16-0EC3-4E7C-8198-9CC8C37F1D50

Q34528276-0989DD22-7E51-46D5-A9EB-2CA26B4B64A3

Q34528276-0FB217CA-01C3-4E43-932B-893966D61877

Q34528276-121F4665-C0A1-4641-A649-C3561DAA3D4C

Q34528276-1407B03C-30A9-48CC-A09B-7A72513C44AD

Q34528276-2EB6F138-A736-4255-8B05-4CC37E8BDC8E

Q34528276-38994A6E-C098-44F9-B362-4E21D81E331C

Q34528276-45B3D1C0-1131-444E-B019-6CFF794E42CD

Q34528276-48E00291-0C1D-40DA-88B2-6F1EE66A5BBA

Q34528276-53994CDE-7144-462C-8DD3-7B94CC7DFA1C

P304

Q34528276-6FBA8776-3272-4365-BB1B-9FA09CDF3BEB

P31

Q34528276-1B554D8A-50EF-4F63-AAC1-AAE973B48C8E

P356

Q34528276-7C6D9170-BE96-467E-A743-CC805098D2B5

P433

Q34528276-EC525D9A-6ED5-4F1B-AD34-EAA03FBD4580

P478

Q34528276-EACE946C-AFE3-466C-90A1-976CBDF62BCB

P50

Q34528276-31AD7142-49DD-489D-BF5D-866BCCD8B228

Q34528276-641819B0-025C-4E5C-9967-B7FF403D73F4

Q34528276-BE1D56D6-1BF9-47A2-AE88-21D38E43A23A

P577

Q34528276-49CDA8DE-E4DC-4B9D-BE91-97CE0830C3D1

P5875

Q34528276-2001E1C5-2F1A-493A-8EFE-B4D995A3110B

P698

Q34528276-3681D6FC-93C0-4155-A53D-D9F6D7DD5EE8

P921

Q34528276-95505E18-2D00-4F81-897B-92F5187C2361

P932

Q34528276-952A4903-26A7-4F75-9383-56B228C44D8C

P356

J.NEO.2014.08.002

P1433

P1476

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer

@en

P2093

Antonio Marchetti

http://www.w3.org/2001/XMLSchema#string

Fiamma Buttitta

http://www.w3.org/2001/XMLSchema#string

Giampietro Gasparini

http://www.w3.org/2001/XMLSchema#string

Ida Pavese

http://www.w3.org/2001/XMLSchema#string

Lara Felicioni

http://www.w3.org/2001/XMLSchema#string

Mario Rosario D'Andrea

http://www.w3.org/2001/XMLSchema#string

Salvatore Tumolo

http://www.w3.org/2001/XMLSchema#string

Stefania Mosconi

http://www.w3.org/2001/XMLSchema#string

Stefano Cordio

http://www.w3.org/2001/XMLSchema#string

P2860

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.

Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer.

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer.

P304

751-756

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEO.2014.08.002

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Angela Buonadonna

Michele De Tursi

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265854308

http://www.w3.org/2001/XMLSchema#string

P698

25246275

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4234870

http://www.w3.org/2001/XMLSchema#string